Back

TransCode study finds TTX-MC138 improves survival in breast cancer bone metastasis model

Verifying
  • TransCode published a study examining TTX-MC138 in a breast cancer bone metastasis model.
  • TTX-MC138 treatment produced significant survival benefits without observed systemic toxicity.
  • The Cancers article was published online on August 23, 2026.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.